Previous studies demonstrated an increased expression of BCR-ABL1 oncogenic fusion protein-kinase and the deregulation of cell cycle proteins that induced DNA damage in CML cells [6]. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.